Back to Search
Start Over
Standard-dose anti-CD20 antibody rituximab has efficacy in chronic lymphocytic leukaemia: results from a Nordic multicentre study
- Source :
- European Journal of Haematology. 69:129-134
- Publication Year :
- 2002
- Publisher :
- Wiley, 2002.
-
Abstract
- Objectives: This prospective multicentre study was conducted to assess the efficacy of the monoclonal anti-CD20 antibody rituximab in patients with chronic lymphocytic leukaemia (CLL). Secondary ob ...
- Subjects :
- Oncology
medicine.medical_specialty
medicine.drug_class
medicine.medical_treatment
Chronic lymphocytic leukemia
Monoclonal antibody
03 medical and health sciences
0302 clinical medicine
immune system diseases
hemic and lymphatic diseases
Internal medicine
Medicine
030304 developmental biology
0303 health sciences
Lymphocytic leukaemia
biology
business.industry
Hematology
General Medicine
Immunotherapy
medicine.disease
3. Good health
Leukemia
030220 oncology & carcinogenesis
Immunology
Monoclonal
biology.protein
Rituximab
Antibody
business
medicine.drug
Subjects
Details
- ISSN :
- 09024441
- Volume :
- 69
- Database :
- OpenAIRE
- Journal :
- European Journal of Haematology
- Accession number :
- edsair.doi...........ae3793b9d128711660649da9507bfd64
- Full Text :
- https://doi.org/10.1034/j.1600-0609.2002.02786.x